Sign up to save your podcasts
Or
Share A “watershed” moment for software stocks…Time to buy small caps?...Pharma drug pricing in focus. 1/29/25
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A “watershed” moment for software stocks…Time to buy small caps?...Pharma drug pricing in focus. 1/29/25
As the AI race heats up, could it be a “watershed” moment for the software stocks? We debate and give you some names to buy. Plus, why the new administration could be bullish for small caps. And, Teva’s CEO discusses the company’s outlook, transition and the future of drug pricing negotiations.
View all episodes
By CNBC
4.9
88 ratings
As the AI race heats up, could it be a “watershed” moment for the software stocks? We debate and give you some names to buy. Plus, why the new administration could be bullish for small caps. And, Teva’s CEO discusses the company’s outlook, transition and the future of drug pricing negotiations.
More shows like CNBC’s “Money Movers”
View all
Mad Money w/ Jim Cramer
4,095 Listeners
CNBC's "Fast Money"
1,358 Listeners
CNBC's "Options Action"
240 Listeners
Your Money Minute
148 Listeners
The Exchange
343 Listeners
Zacks Market Edge
299 Listeners
Fortt Knox
67 Listeners
Strange Success with Jane Wells
155 Listeners
American Greed Podcast
2,172 Listeners
Squawk on the Street
605 Listeners
Squawk Pod
547 Listeners
The Keynote by CNBC Events
20 Listeners
Barron's Live
192 Listeners
Halftime Report
410 Listeners
CNBC's "Last Call"
302 Listeners
Worldwide Exchange
114 Listeners
RiskReversal Pod
780 Listeners
MRKT Matrix
179 Listeners
TechCheck
63 Listeners
Closing Bell
165 Listeners
Power Lunch
25 Listeners
Manifest Space with Morgan Brennan
35 Listeners
CNBC Business News Update
8 Listeners
The Crimes of Putin’s Trader
262 Listeners
CNBC Sport
9 Listeners